See more : Rightmove plc (RTMVF) Income Statement Analysis – Financial Results
Complete financial analysis of Acadia Healthcare Company, Inc. (ACHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Acadia Healthcare Company, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Hana 32 Special Purpose Acquisition Co (475240.KQ) Income Statement Analysis – Financial Results
- Atlas Financial Holdings, Inc. (AFHBL) Income Statement Analysis – Financial Results
- Shipping Corporation of India Land and Assets Limited (SCILAL.NS) Income Statement Analysis – Financial Results
- Concentric AB (publ) (CCNTF) Income Statement Analysis – Financial Results
- PASSUR Aerospace, Inc. (PSSR) Income Statement Analysis – Financial Results
Acadia Healthcare Company, Inc. (ACHC)
About Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.93B | 2.61B | 2.31B | 2.09B | 3.11B | 3.01B | 2.84B | 2.81B | 1.79B | 1.00B | 713.41M | 407.46M | 221.37M | 62.10M |
| Cost of Revenue | 2.25B | 1.49B | 1.33B | 1.24B | 1.84B | 1.78B | 1.65B | 1.66B | 1.05B | 623.83M | 445.53M | 259.14M | 167.94M | 42.36M |
| Gross Profit | 682.61M | 1.12B | 979.89M | 848.17M | 1.27B | 1.23B | 1.19B | 1.15B | 740.10M | 380.77M | 267.88M | 148.33M | 53.44M | 19.74M |
| Gross Profit Ratio | 23.31% | 42.78% | 42.34% | 40.58% | 40.78% | 40.96% | 41.80% | 40.97% | 41.24% | 37.90% | 37.55% | 36.40% | 24.14% | 31.79% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 176.01M | 203.48M | 175.26M | 157.85M | 323.21M | 307.71M | 273.00M | 258.83M | 148.99M | 64.68M | 47.22M | 26.86M | 57.74M | 3.08M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 176.01M | 203.48M | 175.26M | 157.85M | 323.21M | 307.71M | 273.00M | 258.83M | 148.99M | 64.68M | 47.22M | 26.86M | 57.74M | 3.08M |
| Other Expenses | 0.00 | 445.60M | 390.16M | 357.53M | 539.48M | -34.51M | -24.27M | -48.32M | -36.57M | -13.65M | -7.15M | -8.11M | 24.76M | -918.00K |
| Operating Expenses | 176.01M | 649.07M | 565.41M | 515.38M | 862.69M | 821.04M | 747.84M | 706.49M | 419.29M | 208.00M | 144.88M | 77.62M | 82.50M | 10.93M |
| Cost & Expenses | 2.42B | 2.14B | 1.90B | 1.76B | 2.70B | 2.60B | 2.40B | 2.37B | 1.47B | 831.84M | 590.41M | 336.75M | 250.44M | 53.29M |
| Interest Income | 0.00 | 69.76M | 76.99M | 158.11M | 187.33M | 876.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 82.13M | 69.76M | 76.99M | 158.11M | 187.09M | 185.41M | 176.01M | 181.33M | 106.74M | 48.22M | 37.25M | 29.77M | 9.19M | 738.00K |
| Depreciation & Amortization | 132.35M | 117.77M | 106.72M | 95.26M | 87.92M | 158.83M | 143.01M | 135.10M | 63.55M | 32.67M | 17.09M | 7.98M | 4.29M | 976.00K |
| EBITDA | 189.11M | 561.67M | 459.47M | 437.16M | 402.02M | 385.88M | 580.89M | 580.25M | 384.36M | 205.43M | 140.09M | 70.58M | -24.78M | 8.87M |
| EBITDA Ratio | 6.46% | 21.52% | 22.52% | 22.05% | 18.30% | 18.97% | 20.48% | 20.64% | 21.42% | 20.45% | 19.64% | 19.31% | -11.19% | 14.29% |
| Operating Income | 506.60M | 443.90M | 414.47M | 365.61M | 404.53M | 412.74M | 437.88M | 445.14M | 320.81M | 172.76M | 123.00M | 70.71M | -29.07M | 8.81M |
| Operating Income Ratio | 17.30% | 17.01% | 17.91% | 17.49% | 13.02% | 13.70% | 15.44% | 15.84% | 17.88% | 17.20% | 17.24% | 17.35% | -13.13% | 14.19% |
| Total Other Income/Expenses | -531.96M | -72.10M | -120.81M | -148.99M | -235.70M | -581.70M | -201.08M | -412.19M | -156.06M | -46.61M | -53.75M | -37.88M | -5.38M | -1.66M |
| Income Before Tax | -25.36M | 374.14M | 275.76M | 183.80M | 135.99M | -168.95M | 236.80M | 32.96M | 164.75M | 126.15M | 69.25M | 32.83M | -38.26M | 7.16M |
| Income Before Tax Ratio | -0.87% | 14.33% | 11.91% | 8.79% | 4.38% | -5.61% | 8.35% | 1.17% | 9.18% | 12.56% | 9.71% | 8.06% | -17.28% | 11.53% |
| Income Tax Expense | -9.70M | 94.11M | 67.56M | 40.61M | 25.87M | 6.53M | 37.21M | 28.78M | 46.40M | 42.92M | 25.98M | 12.33M | -5.38M | 477.00K |
| Net Income | -21.67M | 273.14M | 190.64M | 143.19M | 108.92M | -175.75M | 199.84M | 6.14M | 119.55M | 83.04M | 42.58M | 20.40M | -34.89M | 6.21M |
| Net Income Ratio | -0.74% | 10.46% | 8.24% | 6.85% | 3.51% | -5.83% | 7.05% | 0.22% | 6.66% | 8.27% | 5.97% | 5.01% | -15.76% | 10.00% |
| EPS | -0.24 | 3.05 | 2.30 | 1.63 | 1.24 | -2.01 | 2.30 | 0.07 | 1.75 | 1.51 | 0.85 | 0.53 | -1.86 | 0.35 |
| EPS Diluted | -0.24 | 2.98 | 2.25 | 1.62 | 1.24 | -2.01 | 2.30 | 0.07 | 1.75 | 1.50 | 0.85 | 0.53 | -1.86 | 0.35 |
| Weighted Avg Shares Out | 90.95M | 89.68M | 88.77M | 87.88M | 87.61M | 87.29M | 86.95M | 85.70M | 68.09M | 55.06M | 50.00M | 38.48M | 18.76M | 17.63M |
| Weighted Avg Shares Out (Dil) | 90.95M | 91.56M | 90.79M | 88.60M | 87.82M | 87.29M | 87.06M | 85.97M | 68.39M | 55.33M | 50.26M | 38.70M | 18.76M | 17.63M |
The Schall Law Firm Urges Shareholder Participation In A Fraud Case Against Acadia Healthcare Company Inc
LOS ANGELES, CA / ACCESSWIRE / December 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Acadia Healthcare Company, Inc. - ACHC
NEW YORK , Dec. 3, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ: ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Acadia Healthcare
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Healthcare To Contact Him Directly To Discuss Their Options
DEADLINE APPROACHING: Berger Montague Advises Acadia Healthcare (NASDAQ: ACHC) Investors to Inquire About a Securities Fraud Class Action by December 16, 2024
PHILADELPHIA, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) on behalf of purchasers of ACADIA securities between...
Lowey Dannenberg Notifies Acadia Healthcare Company, Inc. (“Acadia Healthcare”, or the “Company”) (NASDAQ: ACHC) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Acadia Healthcare Company, Inc. (“Acadia Healthcare”, or the “Company”)...
Is the Options Market Predicting a Spike in Acadia Healthcare (ACHC) Stock?
Investors need to pay close attention to Acadia Healthcare (ACHC) stock based on the movements in the options market lately.
ACHC Deadline: ACHC Investors Have Opportunity to Lead Acadia Healthcare Company, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
NEW YORK , Dec. 2, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the...
ACHC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Acadia Healthcare Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia Healthcare” or “the...
ACHC Investors Have Opportunity to Lead Acadia Healthcare Company Inc. Securities Fraud Lawsuit
LOS ANGELES , Dec. 2, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Acadia Healthcare Company Inc. ("Acadia" or the "Company") (NASDAQ:...
Acadia Healthcare (ACHC) Class Period Expanded After NYT Report That Veterans Affairs Department Is Investigating Allegations of Holding Patients Longer Than Is Medically Necessary – Hagens Berman
SAN FRANCISCO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Acadia Healthcare Company (NASDAQ: ACHC) is facing securities class-action lawsuits by investors alleging the company misled them about its business practices. The more recent lawsuit filed on October 29, 2024 expanded the...
Source: https://incomestatements.info
Category: Stock Reports